bioRxivImmunology
Efficient formation and maintenance of humoral and CD4 T cell immunity targeting the viral capsid in acute-resolving hepatitis E infection
B. Csernalabics, M. S. Marinescu, L. Maurer, L. Kelsch, J. Werner, K. Baumann, K. Zoldan, M. Panning, P. Reuken, T. Bruns, B. Bengsch, C. Neumann-Haefelin, M. Hofmann, R. Thimme, V. L. Dao Thi, T. Boettler
Abstract
Background and aimsCD4 T cells shape the neutralizing antibody (nAb) response and facilitate viral clearance in various infections. Knowledge of their phenotype, specificity and dynamics in hepatitis E virus (HEV) infection is limited. HEV is enterically transmitted as a naked virus (nHEV) but acquires a host-derived quasi-envelope (eHEV) when budding from cells. While nHEV is composed of the open-reading-frame (ORF)-2-derived capsid, eHEV particles also contain ORF3-derived proteins. We aimed to longitudinally characterize the HEV-specific CD4 T cells and neutralizing antibodies that target either nHEV or eHEV particles in immunocompetent individuals with acute and resolved HEV infection. MethodsHEV-specific CD4 T cells were analyzed by intracellular cytokine staining after stimulation with in silico predicted ORF1- and ORF2-derived epitopes and overlapping peptides spanning the ORF3 region. Ex vivo multi-parametric characterization of capsid-specific CD4 T cells was performed using customized MHC class II tetramers. Total and neutralizing antibodies targeting nHEV or eHEV particles were determined. ResultsHEV-specific CD4 T cell frequencies and antibody titers are highest in individuals with acute infection and decline in a time-dependent process with an antigen hierarchy. HEV-specific CD4 T cells primarily target the ORF2-derived capsid, which correlates with the presence of nAbs targeting nHEV. In contrast, ORF3-specific CD4 T cells are hardly detectable and eHEV is less efficiently neutralized. Capsid-specific CD4 T cells undergo memory formation and stepwise contraction, accompanied by dynamic phenotypical and transcriptional changes over time. ConclusionThe viral capsid is the main target of HEV-specific CD4 T cells and antibodies in acute resolving infection, correlating with efficient neutralization of nHEV. Capsid-specific immunity rapidly emerges followed by a stepwise contraction for several years after infection. Impact and implicationsThe interplay of CD4 T cells and neutralizing antibody responses is critical in the host defense against viral infections, yet little is known about their characteristics in hepatitis E virus (HEV) infection. We conducted a longitudinal study of immunocompetent individuals with acute and resolved HEV infection to understand the characteristics of HEV-specific CD4 T cells and neutralizing antibodies targeting different viral proteins and particles. We found that HEV-specific CD4 T cells mainly target the viral capsid, leading to efficient neutralization of the naked virus (nHEV) while the quasi-envelope (eHEV) particles are less susceptible to neutralization. As individuals with pre-existing liver disease and immunocompromised individuals are at risk for fulminant or chronic courses of HEV infection, these individuals might benefit from the development of vaccination strategies which require a detailed knowledge of HEV-specific CD4 T cell and antibody immunity.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The hepatitis E virus capsid protein ORF2 counteracts cell-intrinsic antiviral responses to enable persistence in hepatocytes
Ann-Kathrin Mehnert, Sebastian Stegmaier, … Viet Loan Dao Thi·bioRxiv·Feb 3, 2025
- The Endocytic Recycling Compartment Serves as a Viral Factory for Hepatitis E Virus
C. Bentaleb, K. Hervouet, … L. Cocquerel·bioRxiv·Oct 14, 2021
- Hepatitis E Virus-induced antiviral response by plasmacytoid dendritic cells is modulated by the ORF2 protein
Garima Joshi, Élodie Décembre, … Marlène Dreux·Life Science AlliancePeer-reviewed·Apr 2, 2025
- Consensus native-like hepatitis C virus E1E2 engages broadly neutralizing antibody precursors
Fabian Mulder, Fabien Cannac, … Kwinten Sliepen·bioRxiv·Aug 26, 2026
- Proliferative cell targeting and epithelial cell turnover fuels hepatitis E virus replication in human intestinal enteroids
Nânci Santos-Ferreira, Xin Zhang, … Joana Rocha‐Pereira·Gastro Hep AdvancesPeer-reviewed·Aug 25, 2025
- Modified E2 glycoprotein of hepatitis C virus enhances pro-inflammatory cytokines and protective immune response in mice
V. Vijayamahantesh, T. Patra, … R. Ray·bioRxiv·Feb 7, 2022